基于Copula函数研究莪术-三棱药对治疗“气滞血瘀”证的方剂剂量耦合效应

目的 构建Copula函数，研究莪术Curcuma Rhizoma-三棱Sparganii Rhizoma药对治疗“气滞血瘀”证的方剂剂量耦合效应。方法 从自建方剂数据库中收集治疗“气滞血瘀”证并含莪术-三棱药对的中医方剂，对其中莪术剂量和三棱剂量进行数据处理和检验，从阿基米德Copula函数族、椭圆Copula函数族中选择出最佳的Copula函数建立数学模型，描绘联合分布函数图，测算Kendall秩相关系数和Spearman秩相关系数，监测莪术剂量和三棱剂量数据间的相关性。结果 整理归纳出505首方剂。Gaussian Copula函数模型能较好地反映莪术剂量和三棱剂量之间的相关性，莪术剂量和三棱剂量的Kendall秩相关系数为0.225 6,Spearman秩相关系数为0.333 0，说明莪术剂量和三棱剂量之间具有较强的非线性关系，且呈正相关，当剂量增加时，两者之间的耦合效应会增强。结论 基于Copula函数模型，研究莪术-三棱药对在中医方剂配伍中的剂量相关性，从数据挖掘和数理统计角度为传统经典药对相须为用提供依据，为研究中药药对在中医药方剂配伍中的剂量关系提供新思路。     

房颤伴高血压患者随诊间收缩压波动对预后的影响

目的 探讨收缩压波动对房颤伴高血压患者预后的预测意义 方法 选取2012-2014年于新疆维吾尔自治区人民医院确诊为心房颤动伴高血压的患者，随访其收缩压的变化及平均收缩压，并监测其心源性死亡、急性冠脉综合征、慢性心力衰竭、脑栓塞及外周血管栓塞的发生率。结果在随访的过程中，随着收缩压波动幅度的增加，其终点事件发生率也在不断的增加，收缩压波动最大的四分位组主要终点事件及次要终点事件的发生率是要明显高于收缩压波动最小的四分位组，且患者随诊次数越多，收缩压波动对房颤患者预后的预测意义就越大，这种预测意义在平均收缩压较高的患者中更为明显。结论 收缩压波动可影响房颤伴高血压患者的预后，且收缩压波动越大，房颤患者的预后越不佳。     

Resveratrol induces human K562 cell apoptosis,erythroid differentiation,and autophagy

Resveratrol (Res) is a naturally occurring phytoalexin with apoptotic and inducing-glob effects in leukemic cells, but the potential induction of erythroid differentiation in cells is not fully understood. Here, we investigated the effects of Res on human erythro-megakaryoblastic leukemia cell line K562. Among the treated cells, proliferation was inhibited and the occurrence of cell apoptosis and cell death were detected. Erythroid differentiation assay was explored, and we found that Res could increase the expression of glycophorin A (GPA), HBA1, HBB, and γ-globin genes and enforced the expression of GPA, CD71, and Band3 proteins. Res also induced K562 cell autophagy when the concentration of Res was increased up to 50 or 100 μM. Our findings suggested that Res possesses the potency not only inducing apoptosis but also inducing erythroid differentiation and autophagy in K562 cells. These results provide that Res may be a therapeutic candidate for chronic myelogenous leukemia treatment.     

华泾镇老年人亚临床甲减流行病学调查

目的：研究华泾镇老年人亚临床甲减的流行病学特征。方法：体检筛查、空腹血样，促甲状腺激素＞4.5 mU/L者加测三碘甲状腺游氨酸、游离甲状腺素、甲状腺球蛋白抗体等。结果：65岁以上老年人亚临床甲减患病率为5.03%。除男性70～74岁组外，其余各组随年龄组患病率逐渐升高；同年龄组女性患病率高于男性，但无统计学差异。自身免疫阳性的亚临床甲减患者占24.60%，与非自身免疫阳性的患者无性别、年龄的统计学差异。结论：华泾镇老年人的亚临床甲减患病率与全国报道水平相当，可在老年人中进行适当的防治教育。     

对出院2型糖尿病患者团队干预的效果

目的探讨团队干预对出院2型糖尿病患者血糖水平的影响。方法选择糖化血红蛋白≥10%的出院2型糖尿病患者60例按住院号的单双号分成对照组与观察组各30例。对照组给予常规门诊健康教育和每个月1次的电话随访;观察组由运动专家、神精科(心理)医生、营养师以及糖尿病专科的医护人员等组成干预团队,分别对患者出院后定期的电话随访进行运动指导、营养治疗、心理支持及用药指导和血糖监测等方面的健康教育。结果干预6个月后,观察组餐后2h血糖水平显著低于对照组(P0.05)。两组糖化血红蛋白仍高于7%,差异无统计学意义(P0.05)。结论团队干预有利于出院2型糖尿病患者血糖的控制,应将本干预常态化,以获得更满意的效果。     

The application of color Doppler flow imaging in the diagnosis and therapeutic effect evaluation of erectile dysfunction

We aim to investigate the correlations between hemodynamic parameters, penile rigidity grading, and the therapeutic effects of phosphodiesterase type 5 inhibitors using color Doppler flow imaging after intracavernosal injection in patients with erectile dysfunction. This study involved 164 patients. After intracavernosal injection with a mixture of papaverine (60 mg), prostaglandin E₁ (10 μg), and lidocaine (2%, 0.5–1 ml), the penile vessels were assessed using color Doppler flow imaging. Penile rigidity was classified based on the Erection Hardness Score system as Grades 4, 3, 2 or 1 (corresponding to Schramek Grades V to II). Then, the patients were given oral sildenafil (50–100 mg) and scored according to the International Index of Erectile Function (IIEF-5) questionnaire. The number of patients with penile rigidities of Schramek Grades II to V was 14, 18, 21, and 111, respectively. The IIEF-5 score was positively correlated with the refilling index of the penile cavernosal artery (r = 0.79, P < 0.05), the peak systolic velocity (r = 0.45, P < 0.05), and penile rigidity (r = 0.75, P < 0.05), and was negatively correlated with the end diastolic velocity (r = −0.74, P < 0.05). For patients with erectile dysfunction, both the IIEF-5 score after sildenafil administration, which is correlated with penile rigidity, and the hemodynamic parameters detected using color Doppler flow imaging may predict the effects of phosphodiesterase type 5 inhibitor treatment and could provide a reasonable model for the targeted-treatment of erectile dysfunction.